Abstract
Sorafenib treatment and safety profile in Child Pugh B patients characterized in first interim results of GIDEON (global investigation of therapeutic decisions in hepatocellular carcinoma and of its treatment with sorafenib)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have